Reduced placental transfer of antibodies against microbial and vaccine antigens in HIV-infected women in Mozambique

Published: Aug. 7, 2020, 3:01 p.m.

Link to bioRxiv paper: http://biorxiv.org/cgi/content/short/2020.08.05.237503v1?rss=1 Authors: Alonso, S., Vidal, M., Ruiz-Olalla, G., Gonzalez, R., Manaca, M. N., Jairoce, C., Vazquez-Santiago, M., Balcells, R., Vala, A., Ruperez, M., Cistero, P., Fuente-Soro, L., Cova, M., Angov, E., Nhacolo, A., Sevene, E., Aponte, J. J., Macete, E., Aguilar, R., Mayor, A., Menendez Santos, C., Dobano, C., Moncunill, G. Abstract: Antibody transplacental transfer is essential for conferring protection in newborns against infectious diseases. This transfer may be affected by gestational age and maternal infections, although the effects are not consistent across studies. We measured total IgG and IgG subclasses by quantitative suspension array technology against fourteen pathogens and vaccine antigens, including target of maternal immunization, in 341 delivering HIV- and HIV+ mother-infant pairs from southern Mozambique. Maternal antibody levels were the main determinant of cord antibody levels. HIV broadly reduced the placental transfer and cord levels of IgG and IgG1, but also IgG2 to half of the antigens. Plasmodium falciparum exposure and prematurity were negatively associated with cord antibody levels and placental transfer but this was antigen-subclass dependent. These findings suggest maternal infections may impact the efficacy of maternal immunization and confirm the lower transfer of antibodies as one of the causes underlying increased susceptibility to infections in HIV-exposed infants. Copy rights belong to original authors. Visit the link for more info